Lipid-lowering response of the HMG-CoA r
β
Luis A. Salazar; Mario H. Hirata; Γder C.R. QuintΓ£o; Rosario D.C. Hirata
π
Article
π
2000
π
John Wiley and Sons
π
English
β 63 KB
π 2 views
Although the efficacy of fluvastatin (HMG-CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron